Hemoglobin Oxygen Therapeutics
Development of Oxygen Carrying Solutions
Based in PA
AI Overview
With $0 in lobbying spend across 19 quarterly filings, Hemoglobin Oxygen Therapeutics is an active lobbying client. Their lobbying covers 1 issue area. Active from 2021 to 2025.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2021 | $0 |
| 2022 | $0 |
| 2023 | $0 |
| 2024 | $0 |
| 2025 | $0 |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Hemoglobin Oxygen Therapeutics disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues
Promoting Congressional understanding and awareness of client's core products and therapies, that seek to increase the oxygen-carrying capacity of blood.
Promote and educate lawmakers about client's product that increases the oxygen-carrying capacity of blood.
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.